世界のヒト免疫グロブリン市場予測（～2028年）：B型肝炎免疫グロブリン、狂犬病免疫グロブリン、破傷風免疫グロブリン、その他

• 英文タイトル：Global Human Normal Immunoglobulin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8844 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

ヒト免疫グロブリン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のヒト免疫グロブリンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 ヒト免疫グロブリン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・B型肝炎免疫グロブリン、狂犬病免疫グロブリン、破傷風免疫グロブリン、その他 用途別セグメントは次のように区分されます。 ・政府機関、民間セクター、その他 世界のヒト免疫グロブリン市場の主要な市場プレーヤーは以下のとおりです。 ・CSL Behring、Grifols、Biotest、Kedrion、CBPO、Emergent (Cangene)、Kamada、CNBG、Hualan Bio、Shanghai RAAS、Sichuan Yuanda Shuyang、ADMA Biologics 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、ヒト免疫グロブリン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なヒト免疫グロブリンメーカーの企業概要、2019年～2022年までのヒト免疫グロブリンの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なヒト免疫グロブリンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別ヒト免疫グロブリンの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのヒト免疫グロブリンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのヒト免疫グロブリン市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびヒト免疫グロブリンの産業チェーンを掲載しています。 ・第13、14、15章では、ヒト免疫グロブリンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：CSL Behring、Grifols、Biotest、Kedrion、CBPO、Emergent (Cangene)、Kamada、CNBG、Hualan Bio、Shanghai RAAS、Sichuan Yuanda Shuyang、ADMA Biologics ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：B型肝炎免疫グロブリン、狂犬病免疫グロブリン、破傷風免疫グロブリン、その他 ・用途別分析2017年-2028年：政府機関、民間セクター、その他 ・ヒト免疫グロブリンの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・ヒト免疫グロブリンのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・ヒト免疫グロブリンのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ヒト免疫グロブリンの南米市場規模2017年-2028年：ブラジル、アルゼンチン ・ヒト免疫グロブリンの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Human Normal Immunoglobulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Human Normal Immunoglobulin market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Government Institutions accounting for % of the Human Normal Immunoglobulin global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Hepatitis B Immunoglobulins segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Human Normal Immunoglobulin include CSL Behring, Grifols, Biotest, Kedrion, and CBPO, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Human Normal Immunoglobulin market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Hepatitis B Immunoglobulins
Rabies Immunoglobulins
Tetanus Immunoglobulins
Others
Market segment by Application can be divided into
Government Institutions
Private Sector
Other
The key market players for global Human Normal Immunoglobulin market are listed below:
CSL Behring
Grifols
Biotest
Kedrion
CBPO
Emergent (Cangene)
Kamada
CNBG
Hualan Bio
Shanghai RAAS
Sichuan Yuanda Shuyang
ADMA Biologics
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Normal Immunoglobulin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Normal Immunoglobulin, with price, sales, revenue and global market share of Human Normal Immunoglobulin from 2019 to 2022.
Chapter 3, the Human Normal Immunoglobulin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Normal Immunoglobulin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Human Normal Immunoglobulin market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Human Normal Immunoglobulin.
Chapter 13, 14, and 15, to describe Human Normal Immunoglobulin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Human Normal Immunoglobulin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Normal Immunoglobulin Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Hepatitis B Immunoglobulins
1.2.3 Rabies Immunoglobulins
1.2.4 Tetanus Immunoglobulins
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Normal Immunoglobulin Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Government Institutions
1.3.3 Private Sector
1.3.4 Other
1.4 Global Human Normal Immunoglobulin Market Size & Forecast
1.4.1 Global Human Normal Immunoglobulin Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Human Normal Immunoglobulin Sales in Volume (2017-2028)
1.4.3 Global Human Normal Immunoglobulin Price (2017-2028)
1.5 Global Human Normal Immunoglobulin Production Capacity Analysis
1.5.1 Global Human Normal Immunoglobulin Total Production Capacity (2017-2028)
1.5.2 Global Human Normal Immunoglobulin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Human Normal Immunoglobulin Market Drivers
1.6.2 Human Normal Immunoglobulin Market Restraints
1.6.3 Human Normal Immunoglobulin Trends Analysis
2 Manufacturers Profiles
2.1 CSL Behring
2.1.1 CSL Behring Details
2.1.2 CSL Behring Major Business
2.1.3 CSL Behring Human Normal Immunoglobulin Product and Services
2.1.4 CSL Behring Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Grifols
2.2.1 Grifols Details
2.2.2 Grifols Major Business
2.2.3 Grifols Human Normal Immunoglobulin Product and Services
2.2.4 Grifols Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Biotest
2.3.1 Biotest Details
2.3.2 Biotest Major Business
2.3.3 Biotest Human Normal Immunoglobulin Product and Services
2.3.4 Biotest Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Kedrion
2.4.1 Kedrion Details
2.4.2 Kedrion Major Business
2.4.3 Kedrion Human Normal Immunoglobulin Product and Services
2.4.4 Kedrion Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 CBPO
2.5.1 CBPO Details
2.5.2 CBPO Major Business
2.5.3 CBPO Human Normal Immunoglobulin Product and Services
2.5.4 CBPO Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Emergent (Cangene)
2.6.1 Emergent (Cangene) Details
2.6.2 Emergent (Cangene) Major Business
2.6.3 Emergent (Cangene) Human Normal Immunoglobulin Product and Services
2.6.4 Emergent (Cangene) Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Kamada
2.7.1 Kamada Details
2.7.2 Kamada Major Business
2.7.3 Kamada Human Normal Immunoglobulin Product and Services
2.7.4 Kamada Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 CNBG
2.8.1 CNBG Details
2.8.2 CNBG Major Business
2.8.3 CNBG Human Normal Immunoglobulin Product and Services
2.8.4 CNBG Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Hualan Bio
2.9.1 Hualan Bio Details
2.9.2 Hualan Bio Major Business
2.9.3 Hualan Bio Human Normal Immunoglobulin Product and Services
2.9.4 Hualan Bio Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Shanghai RAAS
2.10.1 Shanghai RAAS Details
2.10.2 Shanghai RAAS Major Business
2.10.3 Shanghai RAAS Human Normal Immunoglobulin Product and Services
2.10.4 Shanghai RAAS Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Sichuan Yuanda Shuyang
2.11.1 Sichuan Yuanda Shuyang Details
2.11.2 Sichuan Yuanda Shuyang Major Business
2.11.3 Sichuan Yuanda Shuyang Human Normal Immunoglobulin Product and Services
2.11.4 Sichuan Yuanda Shuyang Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 ADMA Biologics
2.12.1 ADMA Biologics Details
2.12.2 ADMA Biologics Major Business
2.12.3 ADMA Biologics Human Normal Immunoglobulin Product and Services
2.12.4 ADMA Biologics Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Human Normal Immunoglobulin Breakdown Data by Manufacturer
3.1 Global Human Normal Immunoglobulin Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Human Normal Immunoglobulin Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Human Normal Immunoglobulin
3.4 Market Concentration Rate
3.4.1 Top 3 Human Normal Immunoglobulin Manufacturer Market Share in 2021
3.4.2 Top 6 Human Normal Immunoglobulin Manufacturer Market Share in 2021
3.5 Global Human Normal Immunoglobulin Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Human Normal Immunoglobulin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Human Normal Immunoglobulin Market Size by Region
4.1.1 Global Human Normal Immunoglobulin Sales in Volume by Region (2017-2028)
4.1.2 Global Human Normal Immunoglobulin Revenue by Region (2017-2028)
4.2 North America Human Normal Immunoglobulin Revenue (2017-2028)
4.3 Europe Human Normal Immunoglobulin Revenue (2017-2028)
4.4 Asia-Pacific Human Normal Immunoglobulin Revenue (2017-2028)
4.5 South America Human Normal Immunoglobulin Revenue (2017-2028)
4.6 Middle East and Africa Human Normal Immunoglobulin Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Human Normal Immunoglobulin Sales in Volume by Type (2017-2028)
5.2 Global Human Normal Immunoglobulin Revenue by Type (2017-2028)
5.3 Global Human Normal Immunoglobulin Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Human Normal Immunoglobulin Sales in Volume by Application (2017-2028)
6.2 Global Human Normal Immunoglobulin Revenue by Application (2017-2028)
6.3 Global Human Normal Immunoglobulin Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Human Normal Immunoglobulin Sales by Type (2017-2028)
7.2 North America Human Normal Immunoglobulin Sales by Application (2017-2028)
7.3 North America Human Normal Immunoglobulin Market Size by Country
7.3.1 North America Human Normal Immunoglobulin Sales in Volume by Country (2017-2028)
7.3.2 North America Human Normal Immunoglobulin Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Human Normal Immunoglobulin Sales by Type (2017-2028)
8.2 Europe Human Normal Immunoglobulin Sales by Application (2017-2028)
8.3 Europe Human Normal Immunoglobulin Market Size by Country
8.3.1 Europe Human Normal Immunoglobulin Sales in Volume by Country (2017-2028)
8.3.2 Europe Human Normal Immunoglobulin Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Human Normal Immunoglobulin Sales by Type (2017-2028)
9.2 Asia-Pacific Human Normal Immunoglobulin Sales by Application (2017-2028)
9.3 Asia-Pacific Human Normal Immunoglobulin Market Size by Region
9.3.1 Asia-Pacific Human Normal Immunoglobulin Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Human Normal Immunoglobulin Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Human Normal Immunoglobulin Sales by Type (2017-2028)
10.2 South America Human Normal Immunoglobulin Sales by Application (2017-2028)
10.3 South America Human Normal Immunoglobulin Market Size by Country
10.3.1 South America Human Normal Immunoglobulin Sales in Volume by Country (2017-2028)
10.3.2 South America Human Normal Immunoglobulin Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Human Normal Immunoglobulin Sales by Type (2017-2028)
11.2 Middle East & Africa Human Normal Immunoglobulin Sales by Application (2017-2028)
11.3 Middle East & Africa Human Normal Immunoglobulin Market Size by Country
11.3.1 Middle East & Africa Human Normal Immunoglobulin Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Human Normal Immunoglobulin Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Human Normal Immunoglobulin and Key Manufacturers
12.2 Manufacturing Costs Percentage of Human Normal Immunoglobulin
12.3 Human Normal Immunoglobulin Production Process
12.4 Human Normal Immunoglobulin Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Human Normal Immunoglobulin Typical Distributors
13.3 Human Normal Immunoglobulin Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---